Lyra Therapeutics Inc (LYRA)

Jul 23, 2025

Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus

Jul 22, 2025

Jul 16, 2025

How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser

Jul 16, 2025

Jul 15, 2025

Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru

Jul 15, 2025

Jul 15, 2025

What makes Lyra Therapeutics Inc. stock price move sharplyFree Stock Market Courses - Newser

Jul 15, 2025

Jul 14, 2025

Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada

Jul 14, 2025

Jul 14, 2025

Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria

Jul 14, 2025

Jul 14, 2025

Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com

Jul 14, 2025

Jul 13, 2025

Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World

Jul 13, 2025

Jul 05, 2025

Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 05, 2025

Jun 27, 2025

Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times

Jun 27, 2025

Jun 26, 2025

Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks

Jun 26, 2025

Jun 25, 2025

Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 23, 2025

Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com UK

Jun 23, 2025

Jun 16, 2025

Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha

Jun 16, 2025

Jun 14, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World

Jun 14, 2025

Jun 13, 2025

HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World

Jun 13, 2025

Jun 12, 2025

Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise

Jun 12, 2025

Jun 10, 2025

H.C. Wainwright lifts Lyra Therapeutics stock target to $16 By Investing.com - Investing.com Canada

Jun 10, 2025

Jun 10, 2025

Lyra Therapeutics (LYRA) Price Target Raised by HC Wainwright & Co. | LYRA Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

H.C. Wainwright Ups Target Price for Lyra Therapeutics (LYRA) to $16 | LYRA Stock News - GuruFocus

Jun 10, 2025

Jun 09, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 09, 2025

Jun 09, 2025

Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews

Jun 09, 2025

Jun 07, 2025

Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success - MSN

Jun 07, 2025

Jun 06, 2025

Lyra Eyes US Filing For LYR-210 After Surprise ENLIGHTEN 2 Win - insights.citeline.com

Jun 06, 2025